This study assessed the anti-AD effects of a new class of tricyclic and bicyclic thieno-oxazepine hybrids by contrasting them with donepezil and tacrine, respectively, as AChE and BChE suppressors. The gene discussed is BCHE; the disease is Alzheimer disease.